Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangdong Jiuming Pharmaceutical is a comprehensive pharmaceutical enterprise located in Huizhou, China, dedicated to the research, development, production, and sales of chemical medicines. The company has established a strong presence in the respiratory and anti-allergic therapeutic sectors, with flagship products including Montelukast Sodium and Levocetirizine Hydrochloride. Jiuming Pharmaceutical operates modern, GMP-certified manufacturing facilities and maintains a robust quality management system to ensure product safety and efficacy. In addition to its focus on respiratory health, the company produces a variety of anti-infective and pediatric medications. It aims to expand its market reach through continuous innovation and strategic partnerships within the healthcare industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangdong Jiuming Pharmaceutical.